Premier, Inc.

NasdaqGS:PINC Stock Report

Market Cap: US$2.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Premier Valuation

Is PINC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of PINC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: PINC ($28.26) is trading below our estimate of fair value ($64.12)

Significantly Below Future Cash Flow Value: PINC is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PINC?

Key metric: As PINC is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PINC. This is calculated by dividing PINC's market cap by their current revenue.
What is PINC's PS Ratio?
PS Ratio2.3x
SalesUS$1.00b
Market CapUS$2.34b

Price to Sales Ratio vs Peers

How does PINC's PS Ratio compare to its peers?

The above table shows the PS ratio for PINC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.4x
MD Pediatrix Medical Group
0.9x3.31%US$1.8b
HNGE Hinge Health
5.2x15.41%US$3.1b
ADUS Addus HomeCare
1.5x6.72%US$2.1b
LFST LifeStance Health Group
2x12.94%US$2.7b
PINC Premier
2.3x1.90%US$2.3b

Price-To-Sales vs Peers: PINC is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (2.9x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does PINC's PS Ratio compare vs other companies in the US Healthcare Industry?

35 CompaniesPrice / SalesEstimated GrowthMarket Cap
CVS CVS Health
0.2x3.94%US$99.84b
COR Cencora
0.2x6.71%US$70.19b
CAH Cardinal Health
0.2x8.15%US$51.96b
HUM Humana
0.2x9.56%US$22.20b
PINC 2.3xIndustry Avg. 1.3xNo. of Companies35PS012345+
35 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: PINC is expensive based on its Price-To-Sales Ratio (2.3x) compared to the US Healthcare industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is PINC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PINC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.3x
Fair PS Ratio2.3x

Price-To-Sales vs Fair Ratio: PINC is good value based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

US$28.25
Fair Value
0.04% overvalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/26 19:21
End of Day Share Price 2025/11/24 00:00
Earnings2025/09/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Premier, Inc. is covered by 21 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven ValiquetteBarclays
Stephanie DavisBarclays
Stephanie DavisBarclays